We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$25.8B
AUM Growth
+$4.56B
Cap. Flow
+$3.3B
Cap. Flow %
12.77%
Top 10 Hldgs %
19.43%
Holding
1,157
New
287
Increased
424
Reduced
242
Closed
147

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$997M
2
TXN icon
Texas Instruments
TXN
+$215M
3
NVDA icon
NVIDIA
NVDA
+$209M
4
VZ icon
Verizon
VZ
+$208M
5
APH icon
Amphenol
APH
+$143M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$200M
2
MRUS
Merus
MRUS
+$158M
3
ALL icon
Allstate
ALL
+$141M
4
CB icon
Chubb
CB
+$115M
5
ARGX icon
argenx
ARGX
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 23.32%
3 Financials 10.75%
4 Consumer Discretionary 10.22%
5 Communication Services 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVLT icon
801
Commault Systems
CVLT
$5.59B
$1.59M 0.01%
12,684
-84,273
-87% -$11.9M
AES icon
802
AES
AES
$10.5B
$1.55M 0.01%
108,378
+14,367
+15% +$203K
AME icon
803
Ametek
AME
$57.9B
$1.55M 0.01%
7,565
-80,289
-91% -$15.6M
IOVA icon
804
Iovance Biotherapeutics
IOVA
$2.74B
$1.55M 0.01%
567,680
NCLH icon
805
Norwegian Cruise Line
NCLH
$8.85B
$1.55M 0.01%
69,286
+9,618
+16% +$203K
WYNN icon
806
Wynn Resorts
WYNN
$10.6B
$1.55M 0.01%
12,849
+1,702
+15% +$211K
KURA icon
807
Kura Oncology
KURA
$848M
$1.51M 0.01%
145,704
FDMT icon
808
4D Molecular Therapeutics
FDMT
$561M
$1.5M 0.01%
+200,001
New +$2.03M
TRDA icon
809
Entrada Therapeutics
TRDA
$265M
$1.46M 0.01%
+142,110
New +$1.2M
BETA
810
Beta Technologies Inc
BETA
$5.37B
$1.41M 0.01%
+50,000
New +$1.49M
BLLN
811
BillionToOne Inc
BLLN
$4.4B
$1.39M 0.01%
+17,000
New +$1.72M
BNTC icon
812
Benitec Biopharma
BNTC
$463M
$1.36M 0.01%
+100,704
New +$1.39M
MOH icon
813
Molina Healthcare
MOH
$10.2B
$1.36M 0.01%
+7,813
New +$1.28M
CI icon
814
Cigna
CI
$74.5B
$1.34M 0.01%
+4,884
New +$1.37M
MMM icon
815
3M
MMM
$94.4B
$1.32M 0.01%
8,234
-11,539
-58% -$1.89M
VEEV icon
816
Veeva Systems
VEEV
$37B
$1.31M 0.01%
+5,877
New +$1.56M
COHU icon
817
Cohu
COHU
$2.49B
$1.31M 0.01%
56,148
+20,615
+58% +$472K
ARE icon
818
Alexandria Real Estate Equities
ARE
$8.55B
$1.3M 0.01%
26,540
+5,967
+29% +$351K
BBOT
819
BridgeBio Oncology
BBOT
$745M
$1.3M 0.01%
103,707
ANDG
820
Andersen Group
ANDG
$5.55B
$1.3M 0.01%
+50,000
New +$1.26M
JBIO
821
Jade Biosciences
JBIO
$1.34B
$1.27M ﹤0.01%
+82,056
New +$963K
CAG icon
822
Conagra Brands
CAG
$7.2B
$1.26M ﹤0.01%
72,801
+9,553
+15% +$170K
AMT icon
823
American Tower
AMT
$80.2B
$1.25M ﹤0.01%
+7,126
New +$1.3M
ELV icon
824
Elevance Health
ELV
$85.6B
$1.23M ﹤0.01%
+3,523
New +$1.19M
TEL icon
825
TE Connectivity
TEL
$62.5B
$1.23M ﹤0.01%
+5,405
New +$1.25M

Similar funds

Woodline Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Woodline Partners held 1,157 positions worth $25.8B, up 21% from $21.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $3.3B of net new capital in Q4 2025, opening 287 new positions and adding to 424 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was AT&T, an estimated $200M trimmed.

  • Woodline Partners's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.
  • Woodline Partners added most to Texas Instruments in Q4 2025, an estimated $215M increase.
  • Woodline Partners's biggest Q4 2025 reduction was AT&T, cutting an estimated $200M.
  • Woodline Partners fully exited Merus in Q4 2025, selling an estimated $158M.
  • Woodline Partners's ten largest holdings make up 19% of its $25.8B portfolio in Q4 2025.
  • Woodline Partners opened 287 new positions and closed 147 in Q4 2025.
  • Woodline Partners's portfolio value rose 21% quarter-over-quarter to $25.8B.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.